These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11665289)

  • 1. Impairment of ECM production.
    Horikoshi S; Kanamaru Y; Funabiki K; Tomino Y
    Contrib Nephrol; 2001; (134):63-8. PubMed ID: 11665289
    [No Abstract]   [Full Text] [Related]  

  • 2. Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.
    Pugliese G; Pricci F; Romeo G; Leto G; Amadio L; Iacobini C; Di Mario U
    J Endocrinol Invest; 1999 Oct; 22(9):708-35. PubMed ID: 10595837
    [No Abstract]   [Full Text] [Related]  

  • 3. Transforming growth factor-beta in glomerular injury.
    Border WA; Noble NA
    Exp Nephrol; 1994; 2(1):13-7. PubMed ID: 8081992
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic nephropathy. Mechanisms of mesangial matrix expansion.
    Abrass CK
    West J Med; 1995 Apr; 162(4):318-21. PubMed ID: 7747496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophy and hyperfunction of the diabetic kidney.
    Hostetter TH
    J Clin Invest; 2001 Jan; 107(2):161-2. PubMed ID: 11160131
    [No Abstract]   [Full Text] [Related]  

  • 6. [Physiopathological bases of diabetic nephropathy].
    Savazzi GM; Castiglioni A; Raimondi C; Bocchi B; Celendo MT; Allegri L; Borghetti A
    Recenti Prog Med; 1988 Sep; 79(9):384-91. PubMed ID: 3059423
    [No Abstract]   [Full Text] [Related]  

  • 7. Notch receptors: a new target in glomerular diseases.
    Mertens PR; Raffetseder U; Rauen T
    Nephrol Dial Transplant; 2008 Sep; 23(9):2743-5. PubMed ID: 18503100
    [No Abstract]   [Full Text] [Related]  

  • 8. GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy.
    Heilig CW; Deb DK; Abdul A; Riaz H; James LR; Salameh J; Nahman NS
    Am J Nephrol; 2013; 38(1):39-49. PubMed ID: 23817135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix and its interactions in the diabetic kidney: a molecular biological approach.
    Gilbert RE; Cox A; Dziadek M; Cooper ME; Jerums G
    J Diabetes Complications; 1995; 9(4):252-4. PubMed ID: 8573740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats.
    Furuse Y; Hashimoto N; Maekawa M; Toyama Y; Nakao A; Iwamoto I; Sakurai K; Suzuki Y; Yagui K; Yuasa S; Toshimori K; Saito Y
    Nephron Exp Nephrol; 2004; 98(3):e100-8. PubMed ID: 15528945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions.
    Kitamura M; Sütö TS
    Nephrol Dial Transplant; 1997 Apr; 12(4):669-79. PubMed ID: 9140992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular response to hyperglycemia in human diabetic nephropathy.
    Remuzzi A; Viberti G; Ruggenenti P; Battaglia C; Pagni R; Remuzzi G
    Am J Physiol; 1990 Oct; 259(4 Pt 2):F545-52. PubMed ID: 2221091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.
    Pugliese G; Pricci F; Pesce C; Romeo G; Lenti E; Caltabiano V; Vetri M; Purrello F; Di Mario U
    Diabetes; 1997 Jul; 46(7):1198-206. PubMed ID: 9200656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy.
    Ziyadeh FN; Sharma K
    Kidney Int Suppl; 1995 Sep; 51():S34-6. PubMed ID: 7474686
    [No Abstract]   [Full Text] [Related]  

  • 15. GLUT-1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy.
    Gambaro G; Ceol M; Del Prete D; D'Angelo A
    Nephrol Dial Transplant; 2000 Sep; 15(9):1476-7. PubMed ID: 10978417
    [No Abstract]   [Full Text] [Related]  

  • 16. Mesangial matrix modulation and glomerulosclerosis.
    Fogo AB
    Exp Nephrol; 1999; 7(2):147-59. PubMed ID: 10213868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic nephropathy. I. Pathomorphology and pathogenesis].
    Matuszkiewicz-Rowińska J; Ostrowski K
    Pol Arch Med Wewn; 1992 Jul; 88(1):57-61. PubMed ID: 1454661
    [No Abstract]   [Full Text] [Related]  

  • 18. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.
    Dixon A; Maric C
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1678-90. PubMed ID: 17686959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
    Verrecchia F; Mauviel A
    J Invest Dermatol; 2002 Feb; 118(2):211-5. PubMed ID: 11841535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TGF-beta in the progression of renal fibrosis.
    Tamaki K; Okuda S
    Contrib Nephrol; 2003; 139():44-65. PubMed ID: 12854318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.